Abstract
OBJECTIVES: Availability of direct oral anticoagulants and CHA
METHODS: A retrospective cohort study was conducted using a de-identified data collection sheet for data extraction (demographics, admitting diagnosis, OACT prior to admission and at discharge, concomitant medications that could increase bleed risk and/or acid-suppressive therapies). CHA
RESULTS: Data from 180 patients were evaluated and of these 177 (98.3%) received OACT regardless of stroke risk upon discharge, as determined by CHA
CONCLUSIONS: Decision to add OACT is often guideline-driven, however, individualized circumstances in which clinicians and patients find themselves are also important considerations. Determination of ischemic stroke risk should be performed with CHA
| Original language | American English |
|---|---|
| Pages (from-to) | 22-29 |
| Number of pages | 8 |
| Journal | Hospital Practice |
| Volume | 46 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 18 2017 |
Funding
None
ASJC Scopus Subject Areas
- General Medicine
Keywords
- anticoagulation
- CHA2DS2VASc score
- guideline
- HAS-BLED score
- nonvalvular atrial fibrillation
- pharmacotherapy
- stroke
- Anticoagulation
Disciplines
- Medicine and Health Sciences
- Pharmacy and Pharmaceutical Sciences
Fingerprint
Dive into the research topics of 'Oral Anticoagulation Therapy upon Discharge in Hospitalized Patients with Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS